Deccan Health Care Limited (BOM:542248)
12.65
-0.05 (-0.39%)
At close: Jun 17, 2026
Deccan Health Care Revenue
In the fiscal year ending March 31, 2026, Deccan Health Care had annual revenue of 819.05M INR with 9.12% growth. Deccan Health Care had revenue of 209.75M in the quarter ending March 31, 2026, with 1.10% growth.
Revenue
819.05M
Revenue Growth
+9.12%
P/S Ratio
0.36
Revenue / Employee
9.87M
Employees
83
Market Cap
296.33M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 819.05M | 68.47M | 9.12% |
| Mar 31, 2025 | 750.58M | 153.29M | 25.66% |
| Mar 31, 2024 | 597.29M | 147.07M | 32.67% |
| Mar 31, 2023 | 450.22M | 118.50M | 35.72% |
| Mar 31, 2022 | 331.71M | -6.05M | -1.79% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Murae Organisor | 8.59B |
| Welcure Drugs and Pharmaceuticals | 3.66B |
| JFL Life Sciences | 1.31B |
| ANG Lifesciences India | 862.13M |
| Walpar Nutritions | 757.46M |
| Sandu Pharmaceuticals | 699.35M |
| Panjon | 476.21M |
| Gujarat Terce Laboratories | 474.73M |